Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2002
06/05/2002EP1210329A2 Aminoalkoxy carbazoles and their use as 5-ht ligands
06/05/2002EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands
06/05/2002EP1210086A1 Promotion of wound healing
06/05/2002EP0923551B1 4-aminoethoxy indolone derivatives
06/05/2002EP0888337B1 Piperidone tachykinin antagonists
06/05/2002EP0851855B1 Acylated derivatives of melatonin and its analogues, useful as medicaments
06/05/2002EP0840609B1 Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
06/05/2002EP0790057B1 Antibacterial or bactericide comprising 2-aminothiazole derivative and salts thereof
06/05/2002EP0721942B1 Tetracyclic compound
06/05/2002EP0711282B1 Compounds as pde iv and tnf inhibitors
06/05/2002CN1352642A Farnesyl protein transferase inhibitors
06/05/2002CN1352641A Isonipecotamides for the treatment of integrin mediated disorders
06/05/2002CN1352640A Mutual prodrugs of amlodipine and atorvastatin
06/05/2002CN1352635A Quinoline derivatives as inhibitors of MEK enzymes
06/05/2002CN1085981C Nicotinic acid ester compounds and its salts, their preparation and medicine composition containing them
06/05/2002CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists
06/05/2002CN1085979C Inhibitor for narcotic analgetic dependence/resistance aquisition
06/05/2002CN1085945C 7-(2-imidazolinylamino) quinoline compounds as alpha -2 adrenocepter agonists
06/04/2002USRE37729 Useful as antipsychotic and analgesic agents.
06/04/2002US6399780 Kinase inhibitors; anticancer agents
06/04/2002US6399656 Using a benzopyran-3-carboxamide compound
06/04/2002US6399648 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
06/04/2002US6399631 Carbazole neuropeptide Y5 antagonists
06/04/2002US6399629 Efflux pump inhibitors
06/04/2002US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives
06/04/2002US6399619 Prevention and treatment of aids and viral infection by hiv
06/04/2002US6399615 Farnesyl protein transferase inhibitors
06/04/2002US6399606 3-(((2r)-2-(((2-fluorophenyl)amino)carbonylamino)-2-(methoxy carbonyl)ethylthio)methyl)-4-oxo-4-(3-pyridyl)butanoic acid; treatment of chemotherapy induced neuropathy
06/04/2002US6399603 Therapeutic heterocycles
06/04/2002US6399602 Anticancer agents
06/04/2002CA2364108A1 Acylamino cyclopropane derivatives
06/04/2002CA2257016C Imidazolidin-4-one derivatives useful as anticancer agents
06/04/2002CA2248366C Quinoxalinediones
06/04/2002CA2067929C Piperazine derivatives
06/04/2002CA2060557C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes
06/04/2002CA2029497C 4-acylaminopyridine derivative
05/2002
05/30/2002WO2002042294A1 1-sulfonyl substituted tryptophane derivatives and its use as integrin inhibitors
05/30/2002WO2002042293A1 Isoquinoline derivatives useful in the treatment of cns disorders
05/30/2002WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase
05/30/2002WO2002042291A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors
05/30/2002WO2002042290A1 New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
05/30/2002WO2002042281A1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers
05/30/2002WO2002042280A2 Pyrimidine derivatives
05/30/2002WO2002042279A1 Imidazolone derivatives for the treatment of viral diseases
05/30/2002WO2002042277A1 Novel compounds for use as hiv protease inhibitors
05/30/2002WO2002042273A2 Acid derivatives useful as serine protease inhibitors
05/30/2002WO2002042272A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
05/30/2002WO2002041910A2 Methods and compositions for the treatment of diseases of the eye
05/30/2002WO2002041889A2 Indolsulfonyl compounds useful in the treatment of cns disorders
05/30/2002WO2002041843A2 Antiinflammation agents
05/30/2002WO2002041835A2 Estrogen receptor modulators
05/30/2002WO2002022599A3 Chemokine receptor binding heterocyclic compounds
05/30/2002WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
05/30/2002US20020065422 Fluorescent maleimides and uses thereof
05/30/2002US20020065419 Cyclobutenedione compounds
05/30/2002US20020065418 Viral polymerase inhibitors
05/30/2002US20020065415 For treating cerebral ischemia or cerebral infarction resulting from thromboembolic or hemorrhagic stroke, cerebral vasospasms, hypoglycemia, cardiac arrest, neurodegenerative disorders
05/30/2002US20020065303 Bivalent phenylene inhibitors of factor Xa
05/30/2002US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases
05/30/2002US20020065289 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
05/30/2002US20020065285 Aromatic heterocyclic compounds as antiinflammatory agents
05/30/2002US20020065283 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
05/30/2002US20020065278 Non-imidazole aryloxyalkylamines
05/30/2002US20020065276 N-triazolymethyl-piperazine compounds with neurokinin-receptor antagonist activity
05/30/2002US20020065275 To increase insulin secretion, which makes them useful for treating type II diabetes
05/30/2002US20020065270 For use in therapy of inflammatory diseases such as, for example, rheumatoid arthritis
05/30/2002US20020065269 3-Sulfonylamino-c5 to c8-methyleneimino-2-carboxylic acid compound is effective for prophylaxis and treatment of inflammation, tissue degradation, cancer, fibrosis and related diseases
05/30/2002US20020065265 Antipsychotic sulfonamide-heterocycles, and methods of use thereof
05/30/2002US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis
05/30/2002US20020065192 Productivity catalysts and microstructure control
05/30/2002CA2541946A1 Freeze-dried pantoprazole preparation and pantoprazole injection
05/30/2002CA2430037A1 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
05/30/2002CA2429605A1 Indol derivative and their use as inhibitors of p38 kinase
05/30/2002CA2429570A1 Pyrimidine derivatives
05/30/2002CA2429326A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors
05/30/2002CA2428461A1 Imidazolone derivatives for the treatment of viral diseases
05/30/2002CA2428459A1 Novel compounds for use as hiv protease inhibitors
05/30/2002CA2428191A1 Acid derivatives useful as serine protease inhibitors
05/30/2002CA2427334A1 Methods and compositions for the treatment of diseases of the eye
05/30/2002CA2427284A1 Antiinflammation agents
05/29/2002EP1208188A1 Composition and method for bleaching a substrate
05/29/2002EP1208187A1 Method of bleaching stained fabrics
05/29/2002EP1208186A1 Composition and method for bleaching a substrate
05/29/2002EP1208185A2 Composition and method for bleaching a substrate
05/29/2002EP1208184A1 Method of pretreating and bleaching stained fabrics
05/29/2002EP1208107A2 Ligand and complex for catalytically bleaching a substrate
05/29/2002EP1208101A1 Vitronectin receptor antagonists useful for the treatment of strokes
05/29/2002EP1208097A2 Substituted oxoazaheterocyclyl compounds
05/29/2002EP1208096A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
05/29/2002EP1208091A1 Benzophenones as inhibitors of reverse transcriptase
05/29/2002EP1208085A2 Benzanilides as potassium channel openers
05/29/2002EP1208084A1 Tetrahydropyridines as pesticides
05/29/2002EP1207882A1 Acyclic and cyclic amine derivatives
05/29/2002EP0991637B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors
05/29/2002EP0974583B1 Phenylpiperidine derivatives
05/29/2002CN1351646A Composition and method for bleaching a substrate
05/29/2002CN1351635A Reactive dye compounds
05/29/2002CN1351609A Low-molecular inhibitors of complement proteases
05/29/2002CN1351603A Pesticidal indazole or benzotriazole derivatives
05/29/2002CN1351602A New pharmaceutically active compounds